CA2929863A1 - Cartouche de boisson contenant des actifs pharmaceutiques - Google Patents
Cartouche de boisson contenant des actifs pharmaceutiques Download PDFInfo
- Publication number
- CA2929863A1 CA2929863A1 CA2929863A CA2929863A CA2929863A1 CA 2929863 A1 CA2929863 A1 CA 2929863A1 CA 2929863 A CA2929863 A CA 2929863A CA 2929863 A CA2929863 A CA 2929863A CA 2929863 A1 CA2929863 A1 CA 2929863A1
- Authority
- CA
- Canada
- Prior art keywords
- child
- cartridge
- resistant
- lidding
- another example
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 235000013361 beverage Nutrition 0.000 title description 43
- 238000012360 testing method Methods 0.000 claims abstract description 51
- 239000000463 material Substances 0.000 claims abstract description 30
- 238000012216 screening Methods 0.000 claims abstract description 21
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 20
- 239000011888 foil Substances 0.000 claims description 20
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 11
- -1 polyethylene terephthalate Polymers 0.000 claims description 11
- 229960005489 paracetamol Drugs 0.000 claims description 10
- 229960000520 diphenhydramine Drugs 0.000 claims description 8
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 6
- 229910052782 aluminium Inorganic materials 0.000 claims description 6
- 229920000092 linear low density polyethylene Polymers 0.000 claims description 6
- 239000004707 linear low-density polyethylene Substances 0.000 claims description 6
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 208000024891 symptom Diseases 0.000 claims description 5
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 4
- 230000005540 biological transmission Effects 0.000 claims description 3
- 239000010410 layer Substances 0.000 description 103
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 230000004888 barrier function Effects 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000000853 adhesive Substances 0.000 description 9
- 230000001070 adhesive effect Effects 0.000 description 9
- 210000003811 finger Anatomy 0.000 description 8
- 229920000728 polyester Polymers 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 238000004806 packaging method and process Methods 0.000 description 6
- 239000000825 pharmaceutical preparation Substances 0.000 description 6
- 206010022000 influenza Diseases 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 229940127557 pharmaceutical product Drugs 0.000 description 5
- 229920002493 poly(chlorotrifluoroethylene) Polymers 0.000 description 5
- 239000005023 polychlorotrifluoroethylene (PCTFE) polymer Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 210000003813 thumb Anatomy 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 4
- 241001122767 Theaceae Species 0.000 description 4
- IKZZIQXKLWDPCD-UHFFFAOYSA-N but-1-en-2-ol Chemical compound CCC(O)=C IKZZIQXKLWDPCD-UHFFFAOYSA-N 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 201000009240 nasopharyngitis Diseases 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 3
- 239000004713 Cyclic olefin copolymer Substances 0.000 description 3
- MKXZASYAUGDDCJ-SZMVWBNQSA-N LSM-2525 Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 229960001985 dextromethorphan Drugs 0.000 description 3
- 229920001903 high density polyethylene Polymers 0.000 description 3
- 239000004700 high-density polyethylene Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 229960001802 phenylephrine Drugs 0.000 description 3
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 238000009517 secondary packaging Methods 0.000 description 3
- 229920008790 Amorphous Polyethylene terephthalate Polymers 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- KBAUFVUYFNWQFM-UHFFFAOYSA-N Doxylamine succinate Chemical compound OC(=O)CCC(O)=O.C=1C=CC=NC=1C(C)(OCCN(C)C)C1=CC=CC=C1 KBAUFVUYFNWQFM-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000012459 cleaning agent Substances 0.000 description 2
- 235000020965 cold beverage Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229960005008 doxylamine succinate Drugs 0.000 description 2
- 229940126534 drug product Drugs 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000012171 hot beverage Nutrition 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000002648 laminated material Substances 0.000 description 2
- 229920001684 low density polyethylene Polymers 0.000 description 2
- 239000004702 low-density polyethylene Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 239000004821 Contact adhesive Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 229920010126 Linear Low Density Polyethylene (LLDPE) Polymers 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920006687 PET, APET Polymers 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 239000000850 decongestant Substances 0.000 description 1
- 229940124581 decongestants Drugs 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 229960005178 doxylamine Drugs 0.000 description 1
- HCFDWZZGGLSKEP-UHFFFAOYSA-N doxylamine Chemical compound C=1C=CC=NC=1C(C)(OCCN(C)C)C1=CC=CC=C1 HCFDWZZGGLSKEP-UHFFFAOYSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- BFMKFCLXZSUVPI-UHFFFAOYSA-N ethyl but-3-enoate Chemical compound CCOC(=O)CC=C BFMKFCLXZSUVPI-UHFFFAOYSA-N 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 229940066493 expectorants Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000008921 facial expression Effects 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229960003088 loratadine Drugs 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229940124641 pain reliever Drugs 0.000 description 1
- 239000011087 paperboard Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000009516 primary packaging Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 229960003908 pseudoephedrine Drugs 0.000 description 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 238000012430 stability testing Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials
- B65D85/70—Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for
- B65D85/804—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package
- B65D85/8043—Packages adapted to allow liquid to pass through the contents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/002—Compounding apparatus specially for enteral or parenteral nutritive solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1406—Septums, pierceable membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2093—Containers having several compartments for products to be mixed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2027—Separating means having frangible parts
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Packages (AREA)
- Apparatus For Making Beverages (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Laminated Bodies (AREA)
Abstract
L'invention concerne une cartouche à l'épreuve des enfants, conçue pour être utilisée avec une machine de brassage automatique. La cartouche comprend une base et un opercule. La base peut contenir un actif pharmaceutique. L'opercule peut être un stratifié multicouche ayant une couche extérieure et une couche intérieure. La cartouche peut être faite de matériaux résistants à la déchirure, qui sont suffisants pour empêcher 70 % des enfants d'accéder au contenu de trois ou plusieurs cartouches pendant un test de dépistage à sécurité pour enfants.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361909556P | 2013-11-27 | 2013-11-27 | |
| US61/909,556 | 2013-11-27 | ||
| PCT/US2014/067518 WO2015081145A1 (fr) | 2013-11-27 | 2014-11-26 | Cartouche de boisson contenant des actifs pharmaceutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2929863A1 true CA2929863A1 (fr) | 2015-06-04 |
Family
ID=52014447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2929863A Abandoned CA2929863A1 (fr) | 2013-11-27 | 2014-11-26 | Cartouche de boisson contenant des actifs pharmaceutiques |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP3073981B1 (fr) |
| CN (1) | CN105848625B (fr) |
| AU (2) | AU2014354787B2 (fr) |
| CA (1) | CA2929863A1 (fr) |
| MX (1) | MX2016006449A (fr) |
| RU (1) | RU2669392C1 (fr) |
| WO (1) | WO2015081145A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102015011169B4 (de) * | 2015-09-01 | 2018-12-20 | LigaLife GmbH & Co. KG | Kapsel für eine Erzeugung eines flüssigen Lebensmittels |
| DE102015115250A1 (de) * | 2015-09-10 | 2017-03-16 | Pester Pac Automation Gmbh | Verwendung einer Verpackung |
| US20170280929A1 (en) | 2016-03-30 | 2017-10-05 | Eco 2, Llc | Descaling device for a beverage machine and method of descaling a beverage machine |
| IT201600111266A1 (it) * | 2016-11-04 | 2018-05-04 | Safta Spa | Capsula, metodo di fabbricazione, film multistrato |
| US10881582B2 (en) * | 2018-06-11 | 2021-01-05 | Glaxosmithkline Consumer Healthcare Holdings (Us) Llc | Individual dose pack |
| WO2020039411A2 (fr) * | 2019-09-28 | 2020-02-27 | Famatek Gmbh | Capsule comprenant un ingrédient précurseur principal et un ingrédient précurseur supplémentaire, procédé de production de ladite capsule et procédé de préparation d'une boisson |
| GR1010650B (el) * | 2023-01-17 | 2024-03-12 | Ιουλια Κλεωνος Τσετη | Φαρμακευτικη συνθεση παρακεταμολης υπο υδατοδιαλυτη μορφη εντος ερμητικα κλειστου δοχειου για παρασκευη ζεστου ροφηματος |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1586534A1 (fr) * | 2004-02-18 | 2005-10-19 | MDS Global Holding Ltd. | Distribution d'une substance |
| JP2013514831A (ja) * | 2009-12-18 | 2013-05-02 | グリーン マウンテン コーヒー ロースターズ，インク． | 音波エネルギーを使用した飲料形成装置及び方法 |
| DK2921087T3 (en) * | 2010-02-01 | 2017-01-30 | Keurig Green Mountain Inc | PROCEDURE AND APPARATUS FOR PATTERN-BASED CARBONIZATION OF BEVERAGES |
| US9936834B2 (en) * | 2010-02-01 | 2018-04-10 | Bedford Systems Llc | Method and apparatus for cartridge-based carbonation of beverages |
| DE102011052149A1 (de) * | 2011-07-26 | 2013-01-31 | Cavonic GmbH | Verpackungsbehälter, Herstellungsverfahren sowie Herstellungsvorrichtung |
| ES2675313T3 (es) * | 2012-03-26 | 2018-07-10 | Sarong Societa' Per Azioni | Cápsula para bebidas y métodos para fabricar dicha cápsula |
| CA2902231C (fr) * | 2013-02-25 | 2016-02-09 | 2266170 Ontario Inc. | Capsule contenant une seule portion permettant d'obtenir une efficacite d'extraction et une retention d'arome ameliorees |
-
2014
- 2014-11-26 CN CN201480064906.8A patent/CN105848625B/zh not_active Expired - Fee Related
- 2014-11-26 RU RU2016118811A patent/RU2669392C1/ru not_active IP Right Cessation
- 2014-11-26 EP EP14809262.0A patent/EP3073981B1/fr not_active Not-in-force
- 2014-11-26 CA CA2929863A patent/CA2929863A1/fr not_active Abandoned
- 2014-11-26 MX MX2016006449A patent/MX2016006449A/es active IP Right Grant
- 2014-11-26 AU AU2014354787A patent/AU2014354787B2/en not_active Ceased
- 2014-11-26 WO PCT/US2014/067518 patent/WO2015081145A1/fr active Application Filing
-
2017
- 2017-10-12 AU AU2017245390A patent/AU2017245390B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP3073981A1 (fr) | 2016-10-05 |
| AU2017245390A1 (en) | 2017-11-02 |
| CN105848625A (zh) | 2016-08-10 |
| RU2016118811A (ru) | 2017-12-28 |
| CN105848625B (zh) | 2019-07-09 |
| MX2016006449A (es) | 2016-07-19 |
| AU2014354787B2 (en) | 2017-08-10 |
| AU2014354787A1 (en) | 2016-05-19 |
| EP3073981B1 (fr) | 2019-07-24 |
| WO2015081145A1 (fr) | 2015-06-04 |
| AU2017245390B2 (en) | 2019-03-07 |
| RU2669392C1 (ru) | 2018-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9938075B2 (en) | Beverage cartridge containing pharmaceutical actives | |
| AU2017245390B2 (en) | Beverage cartridge containing pharmaceutical actives | |
| US9744100B2 (en) | Child-resistant blister package | |
| US5511665A (en) | Child-resistant package | |
| ES2590984T3 (es) | Envase de tipo blíster de seguridad para niños | |
| JP5866304B2 (ja) | 医療用ブリスターパッケージの開封システム | |
| US5046618A (en) | Child-resistant blister pack | |
| US5310060A (en) | Tamper-evident, child-resistant blister packages for medicaments and non-medicaments | |
| JP2009233334A (ja) | 医薬品用の引き裂き可能パッケージ及び方法 | |
| MXPA04011000A (es) | Envase blister resistente a ninos. | |
| Lockhart et al. | Packaging of pharmaceuticals and healthcare products | |
| CN112334118A (zh) | 单独剂量包装 | |
| MX2010013298A (es) | Empaque con compartimiento para distribuir dosis de un medicamento. | |
| EP2911948B1 (fr) | Sachet pour un médicament liquide | |
| JP2023511845A (ja) | カスタマイズされたポリピル用の薬局組立機と包装、およびコンプライアンス向上のためのカスタマイズされた抗精神病薬の組み合わせ | |
| EA012345B1 (ru) | Открываемая после сгибания упаковка для таблеток | |
| US7802682B2 (en) | Systems for increasing compliance with a medicament treatment regime | |
| RU2800895C2 (ru) | Упаковка с индивидуальной дозой | |
| WO2024118700A1 (fr) | Capsule de dose individuelle | |
| JP3084962U (ja) | インジケーター付ドリップ吸収シート |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20160505 |
|
| FZDE | Discontinued |
Effective date: 20211015 |